Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 48 | -10 | -40 | 2 | -28 |
| Other Working Capital | 34 | -1,366 | 1,280 | -28 | 64 |
| Other Operating Activity | -633 | -620 | -1,937 | -966 | -721 |
| Operating Cash Flow | $-551 | $-1,996 | $-697 | $-992 | $-685 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 463 | 4,121 | 0 | 0 |
| Financing Cash Flow | $0 | $463 | $4,121 | $0 | $N/A |
| Exchange Rate Effect | -2 | -19 | 20 | -19 | 9 |
| Beginning Cash Position | 5,524 | 7,076 | 3,632 | 4,643 | 5,319 |
| End Cash Position | 4,970 | 5,524 | 7,076 | 3,632 | 4,643 |
| Net Cash Flow | $-551 | $-1,533 | $3,425 | $-992 | $-685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -551 | -1,996 | -697 | -992 | -685 |
| Free Cash Flow | -551 | -1,996 | -697 | -992 | -685 |